Form 4 for EW Edwards Lifesciences
Accepted 2026-07-28 19:40:47 ET · period of report 2026-07-28 · accession 0001225208-26-006777 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-28 19:40 | 2026-07-28 | EW | Markowitz Wayne | CVP, JAPAC | M - OptEx | $74.02 | +9,628 | 31.3K | +44% | +$712.7K |
| D | 2026-07-28 19:40 | 2026-07-28 | EW | Markowitz Wayne | CVP, JAPAC | S - Sale+OE | $85.06 | -9,628 | 21.7K | -31% | -$819.0K |
| D | 2026-07-28 19:40 | 2026-07-28 | EW | Markowitz Wayne | CVP, JAPAC | M - OptEx | $0.00 | -9,628 | 9,628 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-28 | M | A | 9,628 | $74.02 | 31,307.87 | D | — | — | |
| 2 | Common | Common Stock | 2026-07-28 | S | D | 9,628 | $85.06 | 21,679.87 | D | — | — | |
| 3 | Derivative | Employee Stock Option (Right to Acquire) | 2026-07-28 | M | D | 9,628 | $0.00 | 9,628 | D | $74.02 · 2024-09-14 to 2030-09-13 | 9,628 Common Stock |